Research Article Open Access

HER2 Protein Overexpression in Infiltrating Ductal Carcinoma of the Breast Associated with Lymph Node Involvement

Adrienne Pratti Lucarelli, Maria Marta Martins, Vilmar Marques Oliveira, Maria Antonieta Longo Galvão, João Marcelo Guedes, José Francisco Rinaldi, Tsutomo Aoki and Sebastião Piato

Abstract

The current study compares the rates of overexpression of the HER2 protein in stage II ductal carcinoma of breast in patients with lymph-node involvement. The research material was tissue sections obtained from the primary tumor of 28 patients with lymph-node involvement. The technique used to detect the protein was immunohistochemistry. The overexpression of HER2 protein occurred in 33.3% of lymph node-positive patients. Subsequently, the lymph-node metastases population was divided into two subgroups: one subgroup having involvement of up to three lymph nodes and the second subgroup with the involvement of four or more lymph-nodes. In the first group the level of HER2 overexpression was 7.7% and in the second subgroup the HER2 overexpression was 63.6%. The difference was statistically significant.

American Journal of Applied Sciences
Volume 6 No. 3, 2009, 445-448

DOI: https://doi.org/10.3844/ajassp.2009.445.448

Submitted On: 30 April 2008 Published On: 31 March 2009

How to Cite: Lucarelli, A. P., Martins, M. M., Oliveira, V. M., Galvão, M. A. L., Guedes, J. M., Rinaldi, J. F., Aoki, T. & Piato, S. (2009). HER2 Protein Overexpression in Infiltrating Ductal Carcinoma of the Breast Associated with Lymph Node Involvement . American Journal of Applied Sciences, 6(3), 445-448. https://doi.org/10.3844/ajassp.2009.445.448

  • 2,768 Views
  • 2,082 Downloads
  • 1 Citations

Download

Keywords

  • Breast cancer
  • immunohistochemistry
  • HER-2
  • lymph-node metastasis